SFM
FLNA

Sphera Funds Management’s Filana Therapeutics FLNA Stock Holding History

Sphera Funds Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-615,000
Closed -$2.53M – 106
2020
Q1 		$2.53M Buy
+615,000
New +$4.07M 0.32% 50

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sphera Funds Management's FLNA Position: Q2 2020 in Review

Sphera Funds Management sold out of Filana Therapeutics (FLNA) in Q2 2020, closing a stake of 615,000 shares — an estimated $2.53M sold.

Sphera Funds Management first reported a position in FLNA in Q1 2020 and held it in 1 quarter. The position peaked at $2.53M in Q1 2020. 51 funds tracked by Wall St. Rank hold FLNA as of Q2 2020.

  • Sphera Funds Management reported no remaining Filana Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Sphera Funds Management sold 615,000 Filana Therapeutics shares in Q2 2020, an estimated $2.53M.
  • Sphera Funds Management first reported a position in Filana Therapeutics in Q1 2020 and held it in 1 quarter.
  • Sphera Funds Management's Filana Therapeutics position peaked at $2.53M in Q1 2020.
  • 51 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2020.

Based on Sphera Funds Management's 13F filing for Q2 2020, filed 13 Aug 2020.